Guía para la selección de anticuerpos de alto rendimiento para GCase (ID de UniProt: P04062) para su uso en western blot, immunoprecipitación e inmunofluorescencia
Video Experimental Relacionado
Updated: Jan 18, 2026

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
Published on: January 7, 2019
Donovan Worrall1, Charles Alende1, Maryam Fothouhi1
1Neuroscience and Neurosurgery, Montreal Neurological Institute-Hospital, Montreal, Québec, Canada.
Abstract:
The human GBA1 gene encodes glucocerebrosidase (GCase), a lysosomal enzyme that hydrolyzes glucosylceramides. Variants in GBA1 and reduced GCase activity have been linked to Parkinson's disease and Gaucher's disease. Here we have characterized twenty-four GCase commercial antibodies for western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While the use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.

